Answers are grounded in this paper and cite their sources.
Skin cancer represents a growing global health burden with limited efficacy from conventional treatment approaches. Electrospun nanofibers have emerged as promising drug delivery platforms for localized skin cancer therapy, offering advantages including large surface area, tunable porosity, and capacity to maintain drug levels at the tumor site while minimizing systemic exposure. This review consolidates recent advances in electrospinning-based systems for dermatological malignancies, emphasizing material selection, therapeutic incorporation strategies, and functional modifications that enhance treatment effectiveness and skin penetration. Clinical translation challenges and regulatory considerations are addressed to provide a comprehensive overview of electrospun nanofiber technology for future clinical applications in skin cancer management. Additionally, clinical translation challenges, regulatory considerations, and future perspectives encompassing stimuli-responsive systems, targeted delivery, and scalable manufacturing are addressed. Overall, electrospun nanofibers hold significant potential as next-generation, patientfriendly platforms for effective and safe localized skin cancer therapy.
No takes yet. Share an insight, caveat, or question.
P et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: